NMS-1116354
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for NMS-1116354, covering 2012-09-07 to 2012-09-07. Get the full timeline:
Most recent: Clinical Trial Update: Study of NMS-1116354 in Advanced/Metastatic Solid Tumors [Phase 1]